4.6 Article

SMG-1 suppresses CDK2 and tumor growth by regulating both the p53 and Cdc25A signaling pathways

Journal

CELL CYCLE
Volume 12, Issue 24, Pages 3770-3780

Publisher

LANDES BIOSCIENCE
DOI: 10.4161/cc.26660

Keywords

Cdc25A; CDK2; cell cycle; G(1)/S checkpoint; p53; SMG-1; tumorigenesis; tumor suppressor

Categories

Funding

  1. Swedish Cancer Society
  2. Swedish Children's Cancer Foundation
  3. Swedish Research Council
  4. Swedish Pain Relief Foundation
  5. European Research Council
  6. Torsten and Ragnar Soderberg Foundation

Ask authors/readers for more resources

The DNA damage response is coordinated by phosphatidylinositol 3-kinase-related kinases, ATM, ATR, and DNA-PK. SMG-1 is the least studied stress-responsive member of this family. Here, we show that SMG-1 regulates the G(1)/S checkpoint through both a p53-dependent, and a p53-independent pathway. We identify Cdc25A as a new SMG-1 substrate, and show that cells depleted of SMG-1 exhibit prolonged Cdc25A stability, failing to inactivate CDK2 in response to radiation. Given an increased tumor growth following depletion of SMG-1, our data demonstrate a novel role for SMG-1 in regulating Cdc25A and suppressing oncogenic CDK2 driven proliferation, confirming SMG-1 as a tumor suppressor.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available